Bioventus Inc. (BVS) — Financial statements
Income statement, balance sheet, and cash flow for Bioventus Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 568↓0.9% | 573↑11.9% | 512↑0.0% | 512↑18.8% | 431 | |
| Cost of Revenue | 186↑0.3% | 185↑0.5% | 184↑1.7% | 181↑41.2% | 128 | |
| Gross Profit | 382↓1.5% | 388↑18.3% | 328↓0.9% | 331↑9.4% | 303 | |
| Operating Expenses | ||||||
| R&D Expenses | 12↓11.2% | 14↑1.4% | 13↓43.6% | 24↑25.3% | 19 | |
| General & Administrative Expenses | 0.00↓100.0% | 323↑7.5% | 300↓8.2% | 327 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 4↑14.8% | 4↓25.9% | 5 | 0.00 | |
| SG&A Expenses | 312↓4.7% | 327↑7.6% | 304↓8.5% | 332↑30.6% | 254 | |
| Other Expenses | 0.00↓100.0% | 59↓35.8% | 93↓34.9% | 142↑720.2% | 17 | |
| Operating Expenses | 324↓19.1% | 400↓2.4% | 410↓17.7% | 498↑71.5% | 291 | |
| Total Costs & Expenses | 510↓12.9% | 585↓1.5% | 594↓12.6% | 679↑62.2% | 419 | |
| Operating Results | ||||||
| Operating Income | 59↑588.7% | -12↑85.3% | -82↑51.1% | -167↓1486.6% | 12 | |
| Depreciation & Amortization | 47↓5.1% | 50↓13.6% | 57↑3.6% | 55↑58.8% | 35 | |
| EBITDA | 106↑169.1% | 39↑270.0% | -23↑81.0% | -122↓367.4% | 45 | |
| EBIT | 59↑666.5% | -10↑87.2% | -80↑54.6% | -177↓1769.8% | 11 | |
| Interest & Other Income | ||||||
| Net Interest Income | -26↑31.7% | -39↑4.6% | -41↓238.4% | -12↓981.0% | -1 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 26↓31.7% | 39↓4.6% | 41↑238.4% | 12↑981.0% | 1 | |
| Non-Operating Income | 0.00↑100.0% | -2↓27.5% | -1↓113.2% | 10↑568.7% | 1 | |
| Other Income / Expenses | -33↑11.6% | -37↑5.7% | -39↓80.7% | -22↓746.9% | -3 | |
| Income Before Tax | 26↑152.3% | -49↑59.4% | -121↑35.9% | -189↓2092.3% | 9 | |
| Income Tax Expense | -2↑70.4% | -5↓6327.1% | 0.09↑100.2% | -44↓2157.1% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 27↑162.2% | -44↑63.8% | -121↑16.2% | -145↓1362.9% | 11 | |
| Net Income from Discontinued Operations | 0.00 | 0.00↑100.0% | -59↓8.6% | -55↓2832.8% | -2 | |
| Net Income | 23↑167.8% | -34↑78.5% | -156↑1.6% | -159↓919.1% | 19 | |
| Bottom-Line Net Income | 23↑167.8% | -34↑78.5% | -156↑1.6% | -159↓919.1% | 19 | |
| EPS (Basic) | 0.34↑165.4% | -0.52↑79.1% | -2.49↑3.9% | -2.59↓1626.7% | -0.15 | |
| EPS (Diluted) | 0.33↑163.5% | -0.52↑79.1% | -2.49↑3.9% | -2.59↓1626.7% | -0.15 | |
| Weighted Average Shares | 67↑1.9% | 65↑4.3% | 63↑2.0% | 61↑35.0% | 45 | |
| Weighted Average Diluted Shares | 69↑5.4% | 65↑4.3% | 63↑2.0% | 61↑35.0% | 45 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.